R&D Program. The scope of the collaboration between IBP and Diversa during the Research Period will be the areas of discovery, optimization, and development of Compound Sets in the Field, as well as all other aspects of the R&D Program, being defined in more detail in the Work Plan, which is hereby incorporated by reference into this Agreement. The Parties shall work together to identify compounds having potential use in the Field, and intend that IBP may obtain exclusive rights to such Compound Sets, subject to certain diligence and payment obligations as provided in this Agreement.
Appears in 3 contracts
Sources: Drug Discovery, Development, and License Agreement (Intrabiotics Pharmaceuticals Inc /De), Drug Discovery, Development, and License Agreement (Intrabiotics Pharmaceuticals Inc /De), Drug Discovery, Development, and License Agreement (Diversa Corp)